Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma

by Jameel Muzaffar, Shahla Bari, Kedar Kirtane, Christine H. Chung
Published 2021-01-01

Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead

by Daniel Abate-Daga, Christine H Chung, Kedar Kirtane, Hany Elmariah
Published 2021-07-01

Estimation of immune cell content in tumor using single-cell RNA-seq reference data

by Xiaoqing Yu, Y. Ann Chen, Jose R. Conejo-Garcia, Christine H. Chung, Xuefeng Wang
Published 2019-07-01

Deep Learning of Histopathology Images at the Single Cell Level

by Kyubum Lee, John H. Lockhart, Mengyu Xie, Ritu Chaudhary, Robbert J. C. Slebos, Elsa R. Flores, Elsa R. Flores, Christine H. Chung, Christine H. Chung, Aik Choon Tan, Aik Choon Tan
Published 2021-09-01

lncDIFF: a novel quasi-likelihood method for differential expression analysis of non-coding RNA

by Qian Li, Xiaoqing Yu, Ritu Chaudhary, Robbert J. C. Slebos, Christine H. Chung, Xuefeng Wang
Published 2019-07-01

Utilizing a large-scale biobanking registry to assess patient priorities and preferences for cancer research and education.

by Cassandra A Hathaway, Erin M Siegel, Christine H Chung, Smitha Pabbathi, Jennifer Vidrine, Susan Vadaparampil, Shelley S Tworoger
Published 2021-01-01

Epithelial tissues have varying degrees of susceptibility to Kras(G12D)-initiated tumorigenesis in a mouse model.

by Kevin C Ray, Kayla M Bell, Jingbo Yan, Guoqiang Gu, Christine H Chung, M Kay Washington, Anna L Means
Published 2011-02-01

Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis

by Ryan Morrison, Stephen M. Schleicher, Yunguang Sun, Kenneth J. Niermann, Sungjune Kim, Daniel E. Spratt, Christine H. Chung, Bo Lu
Published 2011-01-01

Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome.

by Brittney L Dickey, Bradley Sirak, Laura Martin-Gomez, Richard R Reich, Martha Abrahamsen, Kimberly Isaacs-Soriano, Christine H Chung, Anna R Giuliano
Published 2021-01-01

Preferential activation of the hedgehog pathway by epigenetic modulations in HPV negative HNSCC identified with meta-pathway analysis.

by Elana J Fertig, Ana Markovic, Ludmila V Danilova, Daria A Gaykalova, Leslie Cope, Christine H Chung, Michael F Ochs, Joseph A Califano
Published 2013-01-01

Histoecology: Applying Ecological Principles and Approaches to Describe and Predict Tumor Ecosystem Dynamics Across Space and Time

by Chandler D. Gatenbee PhD, Emily S. Minor PhD, Robbert J. C. Slebos PhD, Christine H. Chung MD, Alexander R. A. Anderson PhD
Published 2020-08-01

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors

by Ezra E. W. Cohen, Michael J. Pishvaian, Dale R. Shepard, Ding Wang, Jared Weiss, Melissa L. Johnson, Christine H. Chung, Ying Chen, Bo Huang, Craig B. Davis, Francesca Toffalorio, Aron Thall, Steven F. Powell
Published 2019-12-01

CancerInSilico: An R/Bioconductor package for combining mathematical and statistical modeling to simulate time course bulk and single cell gene expression data in cancer.

by Thomas D Sherman, Luciane T Kagohara, Raymon Cao, Raymond Cheng, Matthew Satriano, Michael Considine, Gabriel Krigsfeld, Ruchira Ranaweera, Yong Tang, Sandra A Jablonski, Genevieve Stein-O'Brien, Daria A Gaykalova, Louis M Weiner, Christine H Chung, Elana J Fertig
Published 2018-06-01

Regulation of heparin-binding EGF-like growth factor by miR-212 and acquired cetuximab-resistance in head and neck squamous cell carcinoma.

by Hiromitsu Hatakeyama, Haixia Cheng, Pamela Wirth, Ashley Counsell, Samuel R Marcrom, Carey Burton Wood, Paula R Pohlmann, Jill Gilbert, Barbara Murphy, Wendell G Yarbrough, Deric L Wheeler, Paul M Harari, Yan Guo, Yu Shyr, Robbert J Slebos, Christine H Chung
Published 2010-09-01

Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance

by Genevieve Stein-O’Brien, Luciane T. Kagohara, Sijia Li, Manjusha Thakar, Ruchira Ranaweera, Hiroyuki Ozawa, Haixia Cheng, Michael Considine, Sandra Schmitz, Alexander V. Favorov, Ludmila V. Danilova, Joseph A. Califano, Evgeny Izumchenko, Daria A. Gaykalova, Christine H. Chung, Elana J. Fertig
Published 2018-05-01

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

by Bin Li, Jun Li, Tian Chen, Uwe M Martens, Lazar Vujanovic, Rom Leidner, Robert L Ferris, William Sharfman, Chrisann Kyi, Suzanne L Topalian, Janis M Taube, Christine H Chung, William C Spanos, Anthony Gonçalves, Lot A Devriese, Helene Gauthier, Simon I Chiosea, Julie E Stein, Adam Barrows
Published 2021-06-01

A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors

by Aaron S. Mansfield, David S. Hong, Christine L. Hann, Anna F. Farago, Himisha Beltran, Saiama N. Waqar, Andrew E. Hendifar, Lowell B. Anthony, Matthew H. Taylor, Alan H. Bryce, Scott T. Tagawa, Karl Lewis, Jiaxin Niu, Christine H. Chung, James M. Cleary, Michael Rossi, Carrianne Ludwig, Ricardo Valenzuela, Yan Luo, Rahul Aggarwal
Published 2021-08-01

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II St...

by Christine H. Chung, Marcelo Bonomi, Conor E. Steuer, Jiannong Li, Priyanka Bhateja, Matthew Johnson, Jude Masannat, Feifei Song, Juan C. Hernandez-Prera, Bruce M. Wenig, Helen Molina, Joaquim M. Farinhas, Caitlin P. McMullen, J. Trad Wadsworth, Krupal B. Patel, Julie A. Kish, Jameel Muzaffar, Kedar Kirtane, James W. Rocco, Michael J. Schell, Nabil F. Saba
Published 2021-03-01